These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Acne vulgaris: a review of antibiotic therapy. Tan AW; Tan HH Expert Opin Pharmacother; 2005 Mar; 6(3):409-18. PubMed ID: 15794732 [TBL] [Abstract][Full Text] [Related]
29. The Development of Third-Generation Tetracycline Antibiotics and New Perspectives. Rusu A; Buta EL Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959366 [TBL] [Abstract][Full Text] [Related]
30. Minocycline for acne vulgaris: efficacy and safety. Garner SE; Eady EA; Popescu C; Newton J; Li Wan Po A Cochrane Database Syst Rev; 2000; (2):CD002086. PubMed ID: 10796856 [TBL] [Abstract][Full Text] [Related]
31. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. Nishijima S; Kurokawa I; Katoh N; Watanabe K J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198 [TBL] [Abstract][Full Text] [Related]
32. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris. Langner A; Chu A; Goulden V; Ambroziak M Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518 [TBL] [Abstract][Full Text] [Related]
33. Guidelines for the management of acne vulgaris in adolescents. Goulden V Paediatr Drugs; 2003; 5(5):301-13. PubMed ID: 12716217 [TBL] [Abstract][Full Text] [Related]
34. Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome. Batool Z; Lomakin IB; Polikanov YS; Bunick CG Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20530-20537. PubMed ID: 32817463 [TBL] [Abstract][Full Text] [Related]
35. Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris. Oprica C; Emtestam L; Hagströmer L; Nord CE Acta Derm Venereol; 2007; 87(3):246-54. PubMed ID: 17533492 [TBL] [Abstract][Full Text] [Related]
36. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569 [TBL] [Abstract][Full Text] [Related]
37. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance? Kinney MA; Yentzer BA; Fleischer AB; Feldman SR J Drugs Dermatol; 2010 May; 9(5):519-24. PubMed ID: 20480795 [TBL] [Abstract][Full Text] [Related]
39. A Post Hoc Analysis of Efficacy Data on Sarecycline in Hispanics with Acne from Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trials. Moore AY; Hurley K; Moore SA Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671290 [TBL] [Abstract][Full Text] [Related]
40. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne]. Noyon V; Legallou F; Richet H; Dreno B Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]